NCT06031233 2026-03-30
MINUTE
Isala
Phase 4 Recruiting
Clinical Trials
15 trialsNCT05376878 2026-02-23
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
City of Hope Medical Center
Phase 4 Recruiting
NCT04928261 2026-01-22
Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT07093931 2025-07-30
Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer
Shandong Cancer Hospital and Institute
Phase 4 Not yet recruiting
NCT06217185 2024-02-28
The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
Hebei Medical University Fourth Hospital
Phase 4 Recruiting
NCT02419742 2022-10-12
Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
Hoffmann-La Roche
Phase 4 Completed
NCT05420454 2022-07-01
A Study for the Neoadjuvant Treatment of Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Recruiting
NCT05420467 2022-07-01
A Study for the Adjuvant Treatment of Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Recruiting
NCT02445586 2019-10-29
Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT01501487 2018-06-28
MINT
Agendia
Phase 4 Completed
NCT01301729 2016-12-29
A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment
Hoffmann-La Roche
Phase 4 Completed
NCT01260194 2016-11-02
A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer
Hoffmann-La Roche
Phase 4 Terminated
NCT02380131 2015-03-05
Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis
Hebei Medical University
Phase 4 Unknown
NCT00127933 2011-08-10
XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT00171847 2010-03-31
eLEcTRA
Novartis
Phase 4 Terminated